MOH — authorised 9 December 1983
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
MOH authorised Gaviscon on 9 December 1983
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 9 December 1983.
SANOFI AVENTIS US holds the UAE marketing authorisation.